Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ·Healthcare·Biotechnology
$53.86
+23.49%
Mkt Cap $3.18B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $200.81M | $202.13M | +0.66% | $0.29 | $0.17 | -41.38% | — | — |
| Q4 2025 Oct 28, 2025 | $197.09M | $180.85M | -8.24% | $0.33 | $0.23 | -30.30% | — | — |
| Q3 2025 Jul 29, 2025 | $166.48M | $156.80M | -5.82% | $0.18 | $0.23 | +27.78% | — | — |
| Q2 2025 Apr 29, 2025 | $131.88M | $137.78M | +4.48% | $0.02 | $0.11 | +450.00% | — | — |
| Q1 2025 Feb 25, 2025 | $123.42M | $122.54M | -0.71% | -$0.06 | -$0.12 | -100.00% | — | — |
| Q4 2024 Oct 29, 2024 | $123.38M | $112.21M | -9.05% | -$0.02 | -$0.18 | -662.39% | — | — |
| Q3 2024 Jul 23, 2024 | $110.30M | $108.63M | -1.51% | -$0.09 | -$0.06 | +33.33% | — | — |
| Q2 2024 Apr 23, 2024 | $78.46M | $79.86M | +1.78% | -$0.14 | -$0.25 | -78.57% | — | — |
| Q1 2024 Feb 28, 2024 | $72.02M | $83.39M | +15.79% | -$0.11 | $0.04 | +136.36% | — | — |
| Q4 2023 Oct 31, 2023 | $64.45M | $67.05M | +4.03% | -$0.18 | -$0.20 | -11.11% | — | — |
| Q3 2023 Jul 25, 2023 | $62.20M | $71.47M | +14.91% | -$0.16 | -$0.02 | +87.50% | — | — |
| Q2 2023 May 2, 2023 | $46.58M | $48.34M | +3.79% | -$0.18 | -$0.18 | +0.00% | — | — |
| Q1 2023 Feb 28, 2023 | $45.12M | $61.88M | +37.17% | -$0.23 | $0.06 | +126.09% | — | — |
| Q4 2022 Nov 1, 2022 | $93.58M | $99.14M | +5.94% | $0.38 | $0.67 | +76.32% | — | — |
| Q3 2022 Aug 3, 2022 | $28.42M | $26.97M | -5.10% | -$0.43 | -$0.29 | +32.56% | — | — |
| Q2 2022 May 3, 2022 | $30.10M | $32.19M | +6.93% | -$0.52 | -$0.36 | +30.77% | — | — |
| Q1 2022 Feb 22, 2022 | $17.60M | $18.75M | +6.51% | -$0.44 | -$0.53 | -20.45% | — | — |
| Q4 2021 Nov 1, 2021 | $8.78M | $12.10M | +37.76% | -$0.63 | -$0.44 | +30.16% | — | — |
| Q3 2021 Aug 3, 2021 | $7.70M | $7.70M | +0.00% | -$0.69 | -$0.61 | +11.59% | — | — |
| Q2 2021 May 4, 2021 | — | — | — | -$0.73 | -$0.72 | +1.37% | — | — |